US Bancorp’s Rein Therapeutics RNTX Stock Holding History

US Bancorp’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3K	Hold	1,250	–	–	﹤0.01%	3934
2026 Q1	$1.63K	Hold	1,250	–	–	﹤0.01%	3849
2025 Q4	$1.45K	Hold	1,250	–	–	﹤0.01%	3803
2025 Q3	$1.43K	Hold	1,250	–	–	﹤0.01%	3791
2025 Q2	$1.75K	Hold	1,250	–	–	﹤0.01%	3885
2025 Q1	$2.21K	Hold	1,250	–	–	﹤0.01%	3858
2024 Q4	$2.88K	Hold	1,250	–	–	﹤0.01%	3783
2024 Q3	$4.42K	Hold	1,250	–	–	﹤0.01%	3608
2024 Q2	$3.46K	Hold	1,250	–	–	﹤0.01%	3603
2024 Q1	$8.29K	Hold	1,250	–	–	﹤0.01%	3399
2023 Q4	$3.81K	Hold	1,250	–	–	﹤0.01%	3588
2023 Q3	$1.9K	Hold	1,250	–	–	﹤0.01%	3664
2023 Q2	$2.24K	Hold	1,250	–	–	﹤0.01%	3662
2023 Q1	$1.55K	Hold	1,250	–	–	﹤0.01%	3814
2022 Q4	$2.96K	Hold	1,250	–	–	﹤0.01%	3673
2022 Q3	$5K	Hold	1,250	–	–	﹤0.01%	3630
2022 Q2	$7K	Hold	1,250	–	–	﹤0.01%	3493
2022 Q1	$13K	Hold	1,250	–	–	﹤0.01%	3296
2021 Q4	$14K	Hold	1,250	–	–	﹤0.01%	3303
2021 Q3	$26K	Hold	1,250	–	–	﹤0.01%	3002
2021 Q2	$31K	Hold	1,250	–	–	﹤0.01%	2914
2021 Q1	$36K	Hold	1,250	–	–	﹤0.01%	2752
2020 Q4	$26K	Hold	1,250	–	–	﹤0.01%	2801
2020 Q3	$32K	Hold	1,250	–	–	﹤0.01%	2599
2020 Q2	$30K	Hold	1,250	–	–	﹤0.01%	2643
2020 Q1	$8K	Hold	1,250	–	–	﹤0.01%	3116
2019 Q4	$14K	Hold	1,250	–	–	﹤0.01%	3015
2019 Q3	$17K	Hold	1,250	–	–	﹤0.01%	2909
2019 Q2	$18K	Buy	+1,250	New	+$32.8K	﹤0.01%	2928

Other funds holding RNTX

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

US Bancorp's RNTX Position: Q2 2026 in Review

US Bancorp held its Rein Therapeutics (RNTX) position steady in Q2 2026 at 1,250 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3934.

US Bancorp first reported a position in RNTX in Q2 2019 and has held it in 29 quarters since. The position peaked at $36K in Q1 2021. 60 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

US Bancorp held 1,250 shares of Rein Therapeutics worth $1.3K as of Q2 2026.
US Bancorp left its Rein Therapeutics share count unchanged in Q2 2026.
Rein Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3934 holding.
US Bancorp first reported a position in Rein Therapeutics in Q2 2019 and has held it in 29 quarters since.
US Bancorp's Rein Therapeutics position peaked at $36K in Q1 2021.
60 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.